Related Experiment Video
Updated: Oct 8, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Plasminogen activator inhibitor type 2 contains mRNA instability elements within exon 4 of the coding region.
1Department of Medicine, Monash University, Box Hill Hospital, Box Hill 3128, Victoria, Australia.
Abstract:
Plasminogen activator inhibitor type 2 (PAI-2) is a serine protease inhibitor that inhibits urokinase. Constitutive and regulated PAI-2 gene expression involves post-transcriptional events, and an AU-rich mRNA instability motif within the 3'-untranslated region of PAI-2 mRNA is required for this process (Maurer, F., Tierney, M., and Medcalf, R. L. (1999) Nucleic Acids Res. 27, 1664-1673). Here we show that instability determinants are present within various exons of the PAI-2 coding region, most notably within exon 4. Deletion of exon 4 from the full-length PAI-2 cDNA results in a doubling in the half-life of PAI-2 mRNA, whereas a 28-nucleotide region within exon 4 contains binding sites for cytoplasmic proteins. Inducible stabilization of PAI-2 mRNA in HT-1080 cells treated with phorbol ester and tumor necrosis factor does not alter the binding of proteins to the exon 4 instability determinant, but resulted in a transient increase in the binding of factors to the AU-rich RNA instability element. Hence, PAI-2 mRNA stability is influenced by elements located within both the coding region and the 3'-untranslated region and that cytoplasmic mRNA binding factors may influence steady state and inducible PAI-2 mRNA expression. Finally a 10-nucleotide region flanking the exon 4 protein-binding site is homologous to instability elements within five other transcripts, suggesting that a common coding region determinant may exist.
Insights
Plasminogen activator inhibitor type 2 (PAI-2) mRNA stability is regulated by elements in both coding and non-coding regions. Exon 4 and AU-rich elements bind proteins, influencing PAI-2 gene expression.
Area of Science:
- Molecular Biology
- Gene Regulation
Background:
- Plasminogen activator inhibitor type 2 (PAI-2) is a serine protease inhibitor.
- PAI-2 gene expression is regulated post-transcriptionally, involving mRNA stability.
- AU-rich elements in the 3'-untranslated region (UTR) are known to affect PAI-2 mRNA stability.
Purpose of the Study:
- To investigate novel determinants of PAI-2 mRNA stability within its coding region.
- To identify specific sequences and protein interactions that regulate PAI-2 mRNA half-life.
Main Methods:
- Deletion analysis of PAI-2 cDNA, specifically exon 4.
- RNA-protein binding assays using cytoplasmic extracts.
- Analysis of PAI-2 mRNA stabilization in response to cellular stimuli (phorbol ester, TNF).
Main Results:
- Instability determinants were identified within the coding exons of PAI-2, particularly exon 4.
- Deletion of exon 4 significantly increased PAI-2 mRNA half-life.
- A 28-nucleotide region in exon 4 binds cytoplasmic proteins, and this binding is distinct from the AU-rich element binding.
- Inducible mRNA stabilization involved transient changes in binding to the AU-rich element, not the exon 4 determinant.
Conclusions:
- PAI-2 mRNA stability is controlled by elements in both coding (exons) and 3'-UTR regions.
- Cytoplasmic mRNA-binding factors play a role in both basal and inducible PAI-2 mRNA expression.
- A conserved coding region instability element may exist, suggested by homology to other transcripts.
Related Concept Videos
RNA Splicing
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Leaky Scanning
piRNA - Piwi-interacting RNAs
Cytoskeletal Linker Proteins - Plakins
